Literature DB >> 22673518

Knockdown of von Hippel-Lindau protein decreases lung cancer cell proliferation and colonization.

Qiyuan Zhou1, Tianji Chen, Joyce Christina F Ibe, J Usha Raj, Guofei Zhou.   

Abstract

Although von Hippel-Lindau protein (pVHL) is known as a tumor suppressor in kidney and other organs, it remains unclear whether pVHL plays a role in lung cancer development. We investigated the role of pVHL in lung cancer cell proliferation, migration, and colonization using stable A549 cells with knockdown of pVHL. We found that knockdown of pVHL promotes epithelial-mesenchymal transition (EMT) in lung cancer cells. Knockdown of pVHL decreased tumor colonization in a tail-vein injection model and decreased cell proliferation, whereas overexpression of constitutive active HIF increased tumor colonization, suggesting a HIF-independent function of pVHL in lung. Knockdown of pVHL decreased phosphorylation of FAK and expression of integrin, suggesting that pVHL regulates lung cancer development via integrin/FAK signaling pathway.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673518      PMCID: PMC3639012          DOI: 10.1016/j.febslet.2012.04.009

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  49 in total

1.  von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility.

Authors:  M Kamada; K Suzuki; Y Kato; H Okuda; T Shuin
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  A reevaluation of integrins as regulators of angiogenesis.

Authors:  Richard O Hynes
Journal:  Nat Med       Date:  2002-09       Impact factor: 53.440

Review 3.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

4.  Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.

Authors:  M Ohh; C W Park; M Ivan; M A Hoffman; T Y Kim; L E Huang; N Pavletich; V Chau; W G Kaelin
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.

Authors:  N Masson; C Willam; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

7.  Deletion of tumor suppressor genes in Chinese non-small cell lung cancer.

Authors:  Qian An; Yong Liu; Yanning Gao; Jinfeng Huang; Xiaoli Fong; Leyao Liu; Dechao Zhang; Jianjun Zhang; Shujun Cheng
Journal:  Cancer Lett       Date:  2002-10-28       Impact factor: 8.679

Review 8.  Cancer spread and micrometastasis development: quantitative approaches for in vivo models.

Authors:  Ian C MacDonald; Alan C Groom; Ann F Chambers
Journal:  Bioessays       Date:  2002-10       Impact factor: 4.345

9.  Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein.

Authors:  Guofei Zhou; Laura A Dada; Navdeep S Chandel; Kazuhiro Iwai; Emilia Lecuona; Aaron Ciechanover; Jacob I Sznajder
Journal:  FASEB J       Date:  2007-12-11       Impact factor: 5.191

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  7 in total

1.  Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Qiyuan Zhou; Tianji Chen; Wei Zhang; Melike Bozkanat; Yongchao Li; Lei Xiao; Richard B van Breemen; John W Christman; Jacob I Sznajder; Guofei Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

2.  Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.

Authors:  Qiyuan Zhou; Jingbo Dai; Tianji Chen; Laura A Dada; Xu Zhang; Wei Zhang; Malcolm M DeCamp; Robert A Winn; Jacob I Sznajder; Guofei Zhou
Journal:  Cell Signal       Date:  2017-06-24       Impact factor: 4.315

3.  A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis.

Authors:  Namrata Bora-Singhal; Biswarup Saha; Durairaj Mohankumar; Jaya Padmanabhan; Domenico Coppola; Srikumar Chellappan
Journal:  Cancer Res Commun       Date:  2022-07-12

4.  Loss of microRNA-17∼92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5.

Authors:  Tianji Chen; Guofei Zhou; Qiyuan Zhou; Haiyang Tang; Joyce Christina F Ibe; Hongqiang Cheng; Deming Gou; Ju Chen; Jason X-J Yuan; J Usha Raj
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

5.  Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells.

Authors:  Reem Eldawud; Alixandra Wagner; Chenbo Dong; Neha Gupta; Yon Rojanasakul; George O'Doherty; Todd A Stueckle; Cerasela Zoica Dinu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-07-15       Impact factor: 3.770

6.  Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon?

Authors:  Giovanni Pagano; Pavithra Shyamsunder; Rama S Verma; Alex Lyakhovich
Journal:  Oncoscience       Date:  2014-04-21

Review 7.  [Advances of hypoxia and lung cancer].

Authors:  Xuebing Li; Jiacong You; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.